Inari Medical, Inc. Quarterly Debt-to-equity in % from Q1 2021 to Q3 2024

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Inari Medical, Inc. quarterly Debt-to-equity history and growth rate from Q1 2021 to Q3 2024.
  • Inari Medical, Inc. Debt-to-equity for the quarter ending September 30, 2024 was 52.8 %, a 159% increase year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q3 2024 52.8 +32.5 +159% Sep 30, 2024
Q2 2024 43.1 +23.6 +122% Jun 30, 2024
Q1 2024 33.9 +15.3 +82.7% Mar 31, 2024
Q4 2023 26.7 +8.94 +50.3% Dec 31, 2023
Q3 2023 20.4 +1.5 +7.94% Sep 30, 2023
Q2 2023 19.4 -0.96 -4.71% Jun 30, 2023
Q1 2023 18.5 -1.87 -9.16% Mar 31, 2023
Q4 2022 17.8 -2.38 -11.8% Dec 31, 2022
Q3 2022 18.9 +4.57 +31.9% Sep 30, 2022
Q2 2022 20.4 +10.6 +108% Jun 30, 2022
Q1 2022 20.4 +9.06 +79.8% Mar 31, 2022
Q4 2021 20.1 Dec 31, 2021
Q3 2021 14.3 Sep 30, 2021
Q2 2021 9.78 Jun 30, 2021
Q1 2021 11.4 Mar 31, 2021
* An asterisk sign (*) next to the value indicates that the value is likely invalid.